Filing Details
- Accession Number:
- 0001209191-22-046898
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-19 17:31:06
- Reporting Period:
- 2022-07-01
- Accepted Time:
- 2022-08-19 17:31:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1490829 | James Jones | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-07-01 | 30 | $2.11 | 22,228 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-05 | 43 | $2.18 | 22,271 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-06 | 43 | $2.11 | 22,314 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-07 | 43 | $2.18 | 22,357 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-08 | 43 | $2.21 | 22,400 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-12 | 43 | $2.25 | 22,443 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-14 | 43 | $2.28 | 22,486 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-15 | 43 | $2.23 | 22,529 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-18 | 37 | $2.41 | 22,566 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-19 | 37 | $2.47 | 22,603 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-20 | 37 | $2.52 | 22,640 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-21 | 37 | $2.54 | 22,677 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-22 | 37 | $2.53 | 22,714 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-25 | 37 | $2.48 | 22,751 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-26 | 37 | $2.47 | 22,788 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-27 | 30 | $2.36 | 22,818 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-28 | 37 | $2.28 | 22,855 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-07-29 | 37 | $2.28 | 22,892 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-01 | 37 | $2.34 | 22,929 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-03 | 20 | $2.45 | 22,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-04 | 37 | $2.17 | 22,986 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-05 | 37 | $2.12 | 23,023 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-08 | 40 | $2.19 | 23,063 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-09 | 40 | $2.19 | 23,103 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-10 | 40 | $2.19 | 23,143 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-11 | 40 | $2.46 | 23,183 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-12 | 40 | $2.52 | 23,223 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-15 | 32 | $2.45 | 23,255 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.